Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Veterinary dermatology (Print)

• Publication date

  2015-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/vde.12211PMID 25962968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alteration in E-Cadherin/β-Catenin Expression in Canine Melanotic Tumors

  2013cited by this paper
• MicroRNAs as tumour suppressors in canine and human melanoma cells and as a prognostic factor in canine melanomas: MicroRNA expression in canine and human melanomas

  2013cited by this paper
• Beta-catenin inhibits melanocyte migration but induces melanoma metastasis

  2013cited by this paper
• MicroRNAs as tumour suppressors in canine and human melanoma cells and as a prognostic factor in canine melanomas.

  2013cited by this paper
• KIT gene exon 11 mutations in canine malignant melanoma.

  2013cited by this paper
• Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma

  2012cited by this paper
• WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis

  2012cited by this paper
• Evaluation of tyrosinase expression in canine and equine melanocytic tumors.

  2012cited by this paper
• Study of c-kit immunoexpression in canine cutaneous melanocytic tumors

  2012cited by this paper
• Survivin in skin pathologies

  2011cited by this paper
• β-Catenin Signaling Increases during Melanoma Progression and Promotes Tumor Cell Survival and Chemoresistance

  2011cited by this paper
• Prognostic Markers for Canine Melanocytic Neoplasms

  2011cited by this paper
• β-catenin in canine skin: immunohistochemical pattern of expression in normal skin and cutaneous epithelial tumours.

  2011cited by this paper
• Targeting survivin in cancer: the cell-signalling perspective.

  2011cited by this paper
• Lentigines, nevi, and melanomas

  2010cited by this paper
• Dysregulation of the Wnt/β-Catenin Signaling Pathway in Canine Cutaneous Melanotic Tumor

  2010cited by this paper
• Small interfering RNA (siRNA) against the Bcl-2 gene increases apoptosis in a canine melanoma cell line.

  2010cited by this paper
• Fascin, cortactin and survivin expression of melanocytic neoplasms and association with clinicopathological parameters and anatomic locations in Chinese people.

  2010cited by this paper
• Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial.

  2010cited by this paper
• Small interfering RNA (siRNA) against the survivin gene increases apoptosis in a canine melanoma cell line.

  2010cited by this paper
• Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulation.

  2010cited by this paper
• A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers

  2010cited by this paper
• Inactive Wnt/β‐catenin pathway in conventional high‐grade osteosarcoma

  2010cited by this paper
• Survivin: a new target for anti-cancer therapy.

  2009cited by this paper
• Survivin expression in canine epidermis and in canine and human cutaneous squamous cell carcinomas.

  2009cited by this paper
• Activated Wnt/ß-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model

  2009cited by this paper
• Development of vitiligo during melanoma treatment with a novel survivin inhibitor: a case report and review of the literature

  2009cited by this paper
• Caspases and inhibitor of apoptosis proteins in cutaneous and mucosal melanoma: expression profile and clinicopathologic significance.

  2009cited by this paper
• Comparison of pHH3, Ki-67, and Survivin Immunoreactivity in Benign and Malignant Melanocytic Lesions

  2008cited by this paper
• Combinations of apoptosis and cell-cycle control biomarkers predict the outcome of human melanoma.

  2008cited by this paper
• New wirings in the survivin networks

  2008cited by this paper
• Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice.

  2007cited by this paper
• Wnt/beta-catenin signaling in cancer stemness and malignant behavior.

  2007cited by this paper
• Survivin in the human hair follicle.

  2007cited by this paper
• Survivin Identifies Keratinocyte Stem Cells and Is Downregulated by Anti‐β1 Integrin During Anoikis

  2007cited by this paper
• Wnt/β-catenin signaling in cancer stemness and malignant behavior

  2007cited by this paper
• Wnt/beta-catenin signaling in development and disease.

  2006cited by this paper
• Activation of dual apoptotic pathways in human melanocytes and protection by survivin.

  2006cited by this paper
• The WNT/Beta-catenin pathway in melanoma.

  2006cited by this paper
• Nuclear expression of the antiapoptotic protein survivin in malignant melanoma

  2006cited by this paper
• The Histologic and Epidemiologic Bases for Prognostic Considerations in Canine Melanocytic Neoplasia

  2006cited by this paper
• Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi

  2005cited by this paper
• Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine

  2005cited by this paper
• Survivin expression in sentinel lymph nodes from melanoma patients.

  2004cited by this paper
• N-ras mutations in canine malignant melanomas.

  2003cited by this paper
• Apoptosis regulators and responses in human melanocytic and keratinocytic cells.

  2003cited by this paper
• Survivin and molecular pathogenesis of colorectal cancer.

  2003cited by this paper
• Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.

  2003cited by this paper
• Localization of integrin alpha(v)beta3 and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in cutaneous and oral melanomas of dog.

  2003cited by this paper
• Expression and Significance of p53, Rb, p21/waf-1, p16/ink-4a, and PTEN Tumor Suppressors in Canine Melanoma

  2002cited by this paper
• Metallothionein expression in canine and feline mammary and melanotic tumours.

  2001cited by this paper
• Control of apoptosis during angiogenesis by survivin expression in endothelial cells.

  2000cited by this paper
• Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.

  1999cited by this paper
• Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin.

  1999cited by this paper
• Characteristics of Canine Melanomas and Comparison of Histology and DNA Ploidy to Their Biologic Behavior

  1990cited by this paper
• Distal extremity melanocytic nevi and malignant melanomas in dogs.

  1990cited by this paper

• Canine cutaneous melanocytic tumors: main histopathological parameters and the use of a magenta chromogen in immunohistochemical diagnosis

  2025cites this paper
• Detection of bimodal survivin expressions in canine cancer types by flow cytometry compared to immunohistochemistry

  2025cites this paper
• Melanoma of the dog and cat: consensus and guidelines

  2024cites this paper
• Survivin, β-catenin, and ki-67 immunohistochemical expression in canine perivascular wall tumors: Preliminary assessment of prognostic significance

  2024influential citation
• Diagnosis and Prognosis of Canine Melanocytic Neoplasms

  2022cites this paper
• Sox9, Hopx, and survivin and tuft cell marker DCLK1 expression in normal canine intestine and in intestinal adenoma and adenocarcinoma

  2022cites this paper
• Diagnosis and histopathologic prognostication of canine melanocytic neoplasms: A consensus of the Oncology‐Pathology Working Group

  2022influential citation
• H2AFZ: A Novel Prognostic Marker in Canine Melanoma and a Predictive Marker for Resistance to CDK4/6 Inhibitor Treatment

  2021cites this paper
• Melanoma

  2020cites this paper
• MicroRNA expression in formalin-fixed-paraffin-embedded samples of canine cutaneous 3 and oral melanoma by RT-qPCR 4 5

  2019cites this paper
• MicroRNA Expression in Formalin-Fixed, Paraffin-Embedded Samples of Canine Cutaneous and Oral Melanoma by RT-qPCR

  2019cites this paper
• Post-surgical outcome and prognostic factors in canine malignant melanomas of the haired skin: 87 cases (2003-2015).

  2018cites this paper
• Canine squamous cell carcinoma cell lines with high expression of survivin are sensitive to survivin inhibitor YM155.

  2018cites this paper
• Impact and mechanism of non-steroidal anti-inflammatory drugs combined with chemotherapeutic drugs on human lung cancer-nude mouse transplanted tumors.

  2016cites this paper